Treatment of a patient with enophthalmos due to anatomically enlarged posterior–inferior orbital cavities with HA filler injections into the extraconal and inctraconal posterior orbit has been described, which improved his globe position and upper lid hollowness; although, as previously mentioned, there are no studies that identified enophthalmic changes due to GLP1-RA usage [69]. The gene discussed is GCG; the disease is Deeply set eye.